−3.71 MEUR
121.26 KEUR
About PROSTATYPE GENOMICS AB
Sector
CEO
Fredrik Persson
Headquarters
Solna
Website
Employees (FY)
5
Founded
2007
ISIN
SE0014684569
FIGI
BBG00ZVW5ZK2
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. It helps clinicians and patients to make correct treatment decisions. The company was founded in 2007 and is headquartered in Solna, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PROSTATYPE GENOMICS AB stocks are traded under the ticker PGO.
PROSTATYPE GENOMICS AB is going to release the next earnings report on May 23, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track PROSTATYPE GENOMICS AB financials in yearly and quarterly reports right on TradingView.
No, PGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROSTATYPE GENOMICS AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 5.00 employees. See our rating of the largest employees — is PROSTATYPE GENOMICS AB on this list?